aidsoversixty

a reader's journal & virtual public artspace for poz platinum points of view, lgbt political & cultural activism & other metaphoric narratives of the struggle for social justice

Tan Ee Lyn, Reuters, Hong Kong: Children with HIV in Asia suffer resistance to AIDS drugs

Children with HIV in Asia suffer resistance to AIDS drugs
by Tan Ee Lyn, December 1, 2011

chers—

this is the kind of report we will see more often as HIV meds are used as prophylaxis. new virus infecting new persons will already be resistant to meds in this “rich-served-first-to-the-exclusion-of-the-poor-who-were-only-going-to-die-without-paying-anyway” embedded distribution model. it exacerbates the difference between rich and poor globally. the article also raises the problems of pediatric dosage and (non-)access to medicines for the poor, medicines from which big pharma hasn’t finished extracting sufficient profit,

and a vaccine? duh. the most recent advances in the vaccine field were 75 years ago. since then, big pharma has been closing down and not investing in vaccine research facilities (call it infrastructure, if you will), because “virtual” cures pay so much better. a vaccine you get once and you’re done with it. a virtual cure you take multiple versions marked up a hundred- to hundred fifty-fold, forever.

it makes conrad murray look tame by comparison.

—rk

(Reuters) – Teenagers in Asia receiving treatment for HIV are showing early signs of osteoporosis and children as young as five are becoming resistant to AIDS drugs, an anti-AIDS group said on Thursday, urging more attention be given to young HIV patients.

The finding, made available on World AIDS Day, is a reminder that while more people in Asia now have access to basic AIDS drugs, improved medicines remain out of reach and patients — both adults and children — still suffer from inadequate care.

In Asia, some 160,000 children are infected with the human immunodeficiency virus (HIV), which causes AIDS. Of these, 57,000 require treatment but only 30,000 were receiving them as of the end of 2008, according to UNICEF.

Researchers at TREAT Asia found children as young as five were developing resistance to AIDS drugs and may soon require improved, more expensive medicines, which are not available for them yet.

“In our cohort, about 14 percent of the children have failed first-line drugs … Some of the children who are already on second-line are under the age of five,” Annette Sohn, director of TREAT Asia, told Reuters in a phone interview.

Poor adherence to the timing or frequency of taking AIDS drugs results in resistance. But in Asia, resistance is also due to the lack of drug formulations for children.

“We all made some mistakes on how we managed patients with HIV in the beginning of the epidemic,” Sohn said. “We used adult tablets, we had no paediatric formulations in our countries.”

Sohn said health experts and drug providers need to find ways to make third-line, more powerful drugs available for children in poor countries. Such medications are available or subsidized in rich nations but very expensive and sometimes unavailable in developing countries.

“Unless we develop access to third-line drugs, we are going to find ourselves in a clinic room with a patient that there is nothing left and we have no other drug to give them.”

A long-term study of 4,000 HIV patients under the age of 23 in Asia by TREAT Asia also showed that a high percentage of teenagers had low bone mineral density, a precursor of osteoporosis.

“We did a special X-ray on these teenagers who are about 16 years old and found that 15 percent of them had low bone mass,” Sohn said.

“That is not normal. Kids are not supposed to have low bone mass when they’re 16 years old and that’s because of the effect of HIV on their bodies … brain, bone, immune system.”

Sohn, a paediatric specialist for children with HIV/AIDS, said this may also be due to toxic effects that some AIDS drugs, such as tenofovir, have on bone.

“It is not so much about avoiding one drug or another but being aware of these side effects, studying what drug doses will suppress the virus while not being toxic, having the resources to monitor the side effects, and having access to alternate drugs if they do arise.”

The study covers Thailand, Vietnam, Malaysia, Cambodia, Indonesia and India. TREAT Asia is a network of clinics, hospitals and research institutions working together to improve access to treatment for AIDS.

(Editing by Yoko Nishikawa)

Advertisements

Filed under: Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

archives

---pages

blogroll

dictionaries & glossaries

elder links

fourth estate --- journalism, politics, storytelling & watchdoggery

HIV/AIDS specific

lgbt specific

medical cannabis

rhetoric, grammar & logic

wordpress

%d bloggers like this: